The drug "Aurobin" is used to treat diseases of the anogenital zone. The product contains corticosteroids, lidocaine, triclosan and panthenol, due to which the drug has an anti-inflammatory, antiseptic, regenerating effect, reduces pain. This medicine is produced in the form of an ointment.
Ointment "Aurobin" is prescribed for dermatitis, eczema, fistula in the anus. It is also used for hemorrhoids, anal fissures, itching and other pathological processes accompanied by local inflammation.
"Aurobin" is applied externally and rectally. For external use, a small amount of the ointment should be applied to the affected areas 2-4 times a day. With a decrease in the severity of the disease, the frequency of drug use can be reduced to 1-2 times a day. The course of drug treatment lasts 5-7 days. The exact duration of therapy is determined individually and depends on the patient's condition.
When treating internal hemorrhoids, Aurobin ointment should be used rectally. To do this, a pea-sized amount of funds should be injected into the rectum. In this case, it is necessary to use the medicine 1-4 times a day, depending on the severity of the symptoms.
Aurobin ointment can be used to treat children over 1 year old. In this case, it is recommended to use a small amount of the agent: the ointment should be applied to a limited surface, and therapy should be carried out no more than 5 days. The frequency of drug use should also be minimal - 1-2 times a day.
Improper use of the product can lead to its overdose in the body. In particular, excessive administration of ointment into the rectum can provoke cardiac arrhythmias due to the lidocaine contained in the drug. If this phenomenon occurs, it is recommended to reduce the amount of the agent used or to suspend therapy and consult a doctor.
When treating with Aurobin ointment, side effects are possible in the form of skin atrophy, the formation of stretch marks, burning, irritation, dryness, hypertrichosis and the development of a fungal infection at the site of application of the agent. Other skin reactions to corticosteroids are also not excluded. With prolonged treatment, bradycardia may develop.